Recent Quotes (30 days)

You have no recent quotes
chg | %

Amorfix Life Sciences Ltd.  

(Public, TSE:AMF)   Watch this stock  
Find more results for amorifx
+0.0050 (16.67%)
Mar 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.03 - 0.04
52 week 0.03 - 0.45
Open 0.03
Vol / Avg. 59,750.00/94,485.00
Mkt cap 2.42M
P/E     -
Div/yield     -
EPS -0.04
Shares 69.07M
Beta 0.33
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -1200.10% -1519.24%
Operating margin -1200.10% -1519.24%
EBITD margin - -1508.23%
Return on average assets -532.43% -458.43%
Return on average equity -1620.23% -
CDP Score - -


3403 American Drive
+1-416-8476898 (Phone)
+1-416-8476899 (Fax)

Website links


Amorfix Life Sciences Ltd. is a product development company focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases including amyotrophic lateral sclerosis (ALS), cancer and Alzheimer�s disease (AD). The Company is offering two types of products: Therapeutics and Diagnostic Services. The Company's Therapeutics is designed to target and neutralize only the misfolded conformation of a given protein. The Company provides Diagnostic Services using its sensitive and specific Diagnostic Kits to Alzheimer's researchers and prion removal equipment manufacturers. The Company�s product line include ALS Therapeutic Antibody and ALS Therapeutic Vaccine; ALS Diagnostic Test; AD Preclinical A, AD Clinical EP-AD CSF Test; Anti-PrP (ovarian cancer), Anti-Fas (melanoma) and Anti-CD38 (myeloma/leukemia), and Cangene-Amorfix Collaboration.

Officers and directors

William Williams Wyman Chairman of the Board
Age: 76
Robert Gundel Ph.D. President, Chief Executive Officer, Director, IR Contact Officer
Neil Cashman M.D. Chief Scientific Officer, Director
Warren Whitehead Chief Financial Officer, Director
Elliot Goldstein M.D. Director
Age: 63
William Copeland Independent Director
Aziz Mekouar Independent Director
Johannes M. Roth Independent Director
Age: 35